Article and Video CATEGORIES

Cancer Journey

Search By

Clinical Care Options 2018 - Measurable Residual Disease in Acute Lymphoblastic Leukemia
CCO 2018 - MRD in ALL
Author
GRACE Videos and Articles
Image

GRACE has partnered with Clinical Care Options (CCO) Oncology, to share with our community a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).


We are thrilled to share with you video discussions with the following panel:

  • ~Elias Jabbour, MD, Associate Professor Department of Leukemia at the University of Texas MD Anderson Cancer Center in Houston, Texas
  • ~Joseph D. Khoury, MD, Professor, Department of Hematology at the University of Texas MD Anderson Cancer Center in Houston, Texas 
  • ~Aaron C. Logan, MD, Ph.D., Associate Professor Division of Hematology and Blood and Marrow Transplantation at the University of California, San Francisco

In this video series, the doctors discuss MRD in ALL.  Topics include:

Measurable Residual Disease - What Can Physicians Do with MRD Information

Measurable Residual Disease - What Does it Mean to be MRD Positive

Measurable Residual Disease - What is MRD and Why is it Important

Measurable Residual Disease - What Tests Used, How do They Work, and Which is Best for the Patient

Measurable Residual Disease - When Should they Test MRD and How do they get MRD from Patients


For more information about this video program with CCO - please visit https://www.clinicaloptions.com/oncology/programs/mrd-in-all/on-demand-….

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora
Image
Clinical Trials Storytelling 2025
Article
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.